PMEL and neoplasm: Antigens such as glycoprotein 100 (gp100), prostaticacid phosphatase (PAP), and melanoma antigen-encoding gene (MAGE)are discussed elsewhere, along with neoantigens that result from tumor-specificmutations.297 Tumor neoantigens are thesubject of focused reviews.298−300 Peptide-based vaccines for cancerhave also been reviewed elsewhere.300−304 In addition, the uses of peptides to targetcancers caused by infective agents, for example, cervical cancer causedby human papillomavirus (HPV), are discussed.